@article {Broadleye002890, author = {Melanie Broadley and Hannah Chatwin and Uffe S{\o}holm and Stephanie A Amiel and Jill Carlton and Bastiaan E De Galan and Christel Hendrieckx and Rory J McCrimmon and S{\o}ren E Skovlund and Frans Pouwer and Jane Speight}, editor = {, and , and Tack, Cees and Galan, Bastiaan de and Amiel, Stephanie and Choudhary, Pratik and Pieber, Thomas and Mader, Julia and Evans, Mark and Renard, Eric and Pouwer, Frans and Speight, Jane and Thorens, Bernard and Heller, Simon and Brennan, Alan and Pedersen-Bjergaard, Ulrik and McCrimmon, Rory and Haardt, Jakob and Ibberson, Mark and Sparacino, Giovanni and Colhoun, Helen and Gough, Stephen and Milicevic, Zvonko and Kazemi, Mahmood and Cohen, Ohad and Dutta, Sanjoy and Robert, Dominique and Wolf, Wendy and Sullivan, Sean}, title = {The 12-Item Hypoglycemia Impact Profile (HIP12): psychometric validation of a brief measure of the impact of hypoglycemia on quality of life among adults with type 1 or type 2 diabetes}, volume = {10}, number = {4}, elocation-id = {e002890}, year = {2022}, doi = {10.1136/bmjdrc-2022-002890}, publisher = {BMJ Specialist Journals}, abstract = {Introduction The aim of this study was to determine the psychometric properties of the 12-Item Hypoglycemia Impact Profile (HIP12), a brief measure of the impact of hypoglycemia on quality of life (QoL) among adults with type 1 (T1D) or type 2 diabetes (T2D).Research design and methods Adults with T1D (n=1071) or T2D (n=194) participating in the multicountry, online study, {\textquoteleft}Your SAY: Hypoglycemia{\textquoteright}, completed the HIP12. Psychometric analyses were undertaken to determine acceptability, structural validity, internal consistency, convergent/divergent validity, and known-groups validity.Results Most (98\%) participants completed all items on the HIP12. The expected one-factor solution was supported for T1D, T2D, native English speaker, and non-native English speaker groups. Internal consistency was high across all groups (ω=0.91{\textendash}0.93). Convergent and divergent validity were satisfactory. Known-groups validity was demonstrated for both diabetes types, by frequency of severe hypoglycemia (0 vs >=1 episode in the past 12 months) and self-treated episodes (\<2 vs 2{\textendash}4 vs >=5 per week). The measure also discriminated by awareness of hypoglycemia in those with T1D.Conclusions The HIP12 is an acceptable, internally consistent, and valid tool for assessing the impact of hypoglycemia on QoL among adults with T1D. The findings in the relatively small sample with T2D are encouraging and warrant replication in a larger sample.Data are available upon reasonable request. Data are available on reasonable request via contact with the corresponding author (http://orcid.org/0000-0003-4408-6304), provided that data are to be used for research projects related to health sciences. Data are deidentified participant responses from a web-based quantitative survey.}, URL = {https://drc.bmj.com/content/10/4/e002890}, eprint = {https://drc.bmj.com/content/10/4/e002890.full.pdf}, journal = {BMJ Open Diabetes Research and Care} }